652 results on '"Kulka, Janina"'
Search Results
252. Breast Implant-Associated Malignant Lymphoma
253. Solid Papillary Carcinoma
254. Breast Fat Necrosis
255. Usual Ductal Hyperplasia (UDH)
256. Syringomatous Tumor of the Nipple
257. Tubular Adenoma of the Breast
258. Toker Cells of the Nipple
259. Sentinel Node
260. Mucoepidermoid Carcinoma of the Breast
261. Tall Cell Variant of Papillary Breast Carcinoma
262. Sebaceous Carcinoma of the Breast
263. Sclerosing Adenosis
264. Polymorphous Carcinoma
265. Pleomorphic Lobular Carcinoma
266. Phyllodes Tumor
267. Adenosis, Other Types
268. Myoepithelial Carcinoma of the Breast
269. Male Breast Cancer
270. Malignant Adenomyoepithelioma (M-AME)
271. Mammary Myofibroblastoma
272. Low-Grade Adenosquamous Carcinoma
273. Lobular In Situ Neoplasia
274. Acinic Cell Carcinoma
275. Atypical Ductal Hyperplasia
276. Adenomyoepithelioma
277. Atypical Vascular Lesions
278. Apocrine Carcinoma
279. Abscess
280. Angiosarcoma of the Breast
281. Invasive Cribriform Carcinoma
282. Infarct of Breast Tissue
283. Glycogen-Rich Clear Cell Carcinoma
284. Duct Ectasia and Periductal Mastitis
285. Collagenous Spherulosis
286. Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation.
287. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance.
288. Ductal Adenoma
289. Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review.
290. LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.
291. Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?
292. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.
293. Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner.
294. Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
295. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer : a multi-institutional study
296. Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width.
297. Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR).
298. Digital Whole Slide Image Analysis of Elevated Stromal Content and Extracellular Matrix Protein Expression Predicts Adverse Prognosis in Triple-Negative Breast Cancer.
299. TRPS1 expression in breast angiosarcoma.
300. Research autopsy programmes in oncology: shared experience from 14 centres across the world.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.